:Exaprolol

{{Chembox

| ImageFile = Exaprolol.svg

| ImageSize = 200px

| ImageAlt =

| IUPACName = 1-(2-Cyclohexylphenoxy)-3-(propan-2-ylamino)propan-2-ol

| OtherNames = Esprolol

|Section1={{Chembox Identifiers

| CASNo = 55837-19-9

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = Q4XX54I93R

| PubChem = 65485

| ChemSpiderID = 58934

| KEGG = D04120

| InChI=1S/C18H29NO2/c1-14(2)19-12-16(20)13-21-18-11-7-6-10-17(18)15-8-4-3-5-9-15/h6-7,10-11,14-16,19-20H,3-5,8-9,12-13H2,1-2H3

| InChIKey= ABXHHEZNIJUQFM-UHFFFAOYSA-N

| SMILES = CC(C)NCC(COC1=CC=CC=C1C2CCCCC2)O}}

|Section2={{Chembox Properties

| C=18 | H=29 | N=1 | O=2

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Exaprolol is a beta-adrenoceptor antagonist.{{cite journal|pmid=17961850|year=2008|last1=Van Waarde|first1=A|last2=Doorduin|first2=J|last3=De Jong|first3=JR|last4=Dierckx|first4=RA|last5=Elsinga|first5=PH|title=Synthesis and preliminary evaluation of (S)-11C-exaprolol, a novel beta-adrenoceptor ligand for PET|volume=52|issue=4–5|pages=729–33|doi=10.1016/j.neuint.2007.09.009|journal=Neurochemistry International}}